Criteria for disease activity in Wegener's granulomatosis: a requirement for longitudinal clinical studies.
Kallenberg
C G
CG
Dept. of Clinical Immunology, University Hospital, Groningen, The Netherlands.
Tervaert
J W
JW
Stegeman
C A
CA
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000627:therapeutic use; D014890:Granulomatosis with Polyangiitis / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D006801:Humans; D008137:Longitudinal Studies
D000305:Adrenal Cortex Hormones; D003520:Cyclophosphamide